Cargando…
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis()()
Mammalian target of rapamycin complex 2 (mTORC2) with its pivotal component rapamycin-insensitive companion of mTOR (RICTOR) is the major regulator of AKT phosphorylation and is increasingly implicated in tumor growth and progression. In cutaneous melanoma, an extremely aggressive and highly metasta...
Autores principales: | Schmidt, Katharina M., Dietrich, Peter, Hackl, Christina, Guenzle, Jessica, Bronsert, Peter, Wagner, Christine, Fichtner-Feigl, Stefan, Schlitt, Hans J., Geissler, Edward K., Hellerbrand, Claus, Lang, Sven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224335/ https://www.ncbi.nlm.nih.gov/pubmed/30404068 http://dx.doi.org/10.1016/j.neo.2018.10.001 |
Ejemplares similares
-
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
por: Guenzle, Jessica, et al.
Publicado: (2020) -
Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
por: Schmidt, Katharina M., et al.
Publicado: (2017) -
Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases
por: Joechle, Katharina, et al.
Publicado: (2022) -
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
por: Lee, Dongjun, et al.
Publicado: (2014) -
Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis
por: Kocalis, Heidi E., et al.
Publicado: (2014)